The Race to Prepare for Medicare’s New Drug Pricing Powers
The Inflation Reduction Act gives Medicare historic new powers to control prescription drug prices. We go inside the government’s race to implement these new powers — and the pharmaceutical industry’s efforts to blunt their impact.
Alice Valder Curran, JD, Partner, Hogan Lovells
Sean Dickson, JD, MPH, Director of Health Policy, West Health Policy Center
Amber Jessup, PhD, Chief Economist, Office of Inspector General, Department of Health and Human Services
Mark Newsom, Founder and Principal, Health Evaluations
Learn more and read a full transcript on our website.
Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.
Support this type of journalism today, with a gift.
Follow us on Twitter.